[membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has signed a Memorandum of Understanding (MoU) with its Swiss counterpart, Swissmedic, which calls for: ● a shared approach to complex challenges, and ● promotion of each other’s regulatory frameworks, requirements, and processes. Significant outcomes will include the facilitation and exchange of information. “We operate in a global environment and agreements such as these serve to further strengthen our ability to promote good practices,” MHRA Chief Executive Ian Hudson said.
[/membership]
INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue
